Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01907334 · ClinicalTrials.gov registry record · Phase 4
Dose-Response of Salmeterol in Children
A Phase 4 study, sponsored by University of Florida.
- Completed
- Registry status
- Phase 4
- Development phase
- 10
- Enrollment target
NCT01907334 is a Phase 4 study that has completed, run by University of Florida. The registered enrollment target is 10 participants.
The verdict
NCT01907334, a Phase 4 study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 10 participants
- Enrollment target
Study Summary
To examine whether a breathing test (methacholine challenge using impulse oscillometry) can be used to tell the difference between two different doses of an inhaled drug, salmeterol, delivered by Advair in children with asthma
Interventions
- DRUG Albuterol
- DRUG Advair Diskus100/50 µg
- DRUG Flovent Diskus 100 µg
- DRUG Methacholine Chloride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2013-08 |
| Est. Completion | 2014-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01907334
The ClinicalTrials.gov registry entry for NCT01907334 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Albuterol is the first listed.
NCT01907334 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01907334 about?
NCT01907334 is a clinical study titled "Dose-Response of Salmeterol in Children". To examine whether a breathing test (methacholine challenge using impulse oscillometry) can be used to tell the difference between two different doses of an inhaled drug, salmeterol, delivered by Advair in children with asthma
What is the current status of trial NCT01907334?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 10 participants. The study started on 2013-08. Estimated completion is 2014-07.
What interventions are being tested in trial NCT01907334?
The interventions under investigation include: Albuterol (DRUG), Advair Diskus100/50 µg (DRUG), Flovent Diskus 100 µg (DRUG), Methacholine Chloride (DRUG).
Who is sponsoring clinical trial NCT01907334?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.